6Y4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vicore Pharma Holding AB

Watchlist Manager

Watchlist

Price: 0.839 EUR -0.59%

Market Cap: €93.7m

	Vicore Pharma Holding AB F:6Y4	SE
G	Global Power Synergy PCL SET:GPSC	TH
	ANTA Sports Products Ltd OTC:ANPDY	CN
	Bharat Electronics Ltd NSE:BEL	IN
	McDermott International Ltd OTC:MCDIF	US
G	Goldman Sachs Group Inc DUS:GOS	US
	Waratah Minerals Ltd ASX:WTM	AU
P	PostNL NV DUS:TNTC	NL

Profitability Summary

Vicore Pharma Holding AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-13 110%

Negative 3Y Average Operating Margin

-5 415%

Negative Net Margin

-12 570%

Negative 3Y Average Net Margin

-5 426%

Negative Free Cash Flow Margin

-11 435%

Negative 3Y Average Free Cash Flow Margin

-4 632%

Negative ROE

-57%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3 230%

Declining ROIC

-607% > -7 287%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.